RADICAVA (edaravone) stands at the forefront of amyotrophic lateral sclerosis intervention, delivering meaningful therapeutic impact for patients navigating motor neuron decline. Commercial success over recent years reflects a positive shift, with growing numbers of patients and clinicians embracing infusion-based treatment strategies. The arrival of RADICAVA ORS in oral suspension form...
French 
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt